We are live on ! Find out more
MBOT icon

Microbot Medical

36 hedge funds and large institutions have $8.18M invested in Microbot Medical in 2014 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 7

9% more funds holding

Funds holding: 3336 (+3)

1% more capital invested

Capital invested by funds: $8.11M → $8.18M (+$68K)

Holders
36
Holders Change
+3
Holders Change %
+9.09%
% of All Funds
1.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
14
Reduced
7
Closed
2
Calls
Puts
Net Calls
Net Calls Change

MBOT Hedge Fund Activity: Q1 2014 in Review

36 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2014, worth a combined $8.18M — up 0.84% from $8.11M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new MBOT positions and 2 closed out — a net gain of 3 holders — while 14 added to existing stakes and 7 trimmed.

The largest buyer was BlackRock Institutional Trust, adding an estimated $600K. The largest seller was Sabby Management, exiting entirely with an estimated $1.04M sold.

  • 36 institutional investors held Microbot Medical (MBOT) as of Q1 2014, up from 33 in Q4 2013.
  • Funds reported $8.18M of Microbot Medical stock for Q1 2014, up 0.84% quarter-over-quarter.
  • 5 funds opened new Microbot Medical positions in Q1 2014 and 2 closed out, a net change of +3 holders.
  • The largest Microbot Medical buyer in Q1 2014 was BlackRock Institutional Trust, an estimated $600K added.
  • The largest Microbot Medical seller in Q1 2014 was Sabby Management, an estimated $1.04M sold.

Based on aggregated 13F filings for Q1 2014.